Poland· PL-100226043
Rutinosal C
A medicinal product containing salicis cortex + rutinum + acidum ascorbicum, registered in Poland by Labofarm sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Salicis cortex + Rutinum + Acidum ascorbicum
- Manufacturer
- Labofarm sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991052720
- gtin05909991052737
- gtin05909991052713
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/516c2228-5e86-47a7-84e1-9ec374620a02 GET /v1/drugs/516c2228-5e86-47a7-84e1-9ec374620a02?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "300 mg + 20 mg + 40 mg",
"packaging": "05909991052720 ¦ OTC ¦ 23008\n60 tabl.\n05909991052737 ¦ OTC ¦ 23009\n90 tabl.\n05909991052713 ¦ OTC ¦ 61528\n30 tabl.",
"substance": "Salicis cortex 300 mg + Rutosidum trihydricum 20 mg + Acidum ascorbicum 40 mg",
"common_name": "Salicis cortex + Rutinum + Acidum ascorbicum",
"pl_product_id": "100226043",
"pozwolenie_nr": "10527",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about salicis cortex + rutinum + acidum ascorbicum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.